Anyone considering a psychedelic or MDMA-assisted session in the Netherlands will soon realize that practical questions are at least as important as the substantive ones: how many days should you plan, what are the legal implications, and what happens during the intake? Many definitive statements circulate online regarding this. In this article, we calmly outline the key points: what you can and cannot expect from MDMA therapy in the Netherlands, what the intake and planning typically look like, and what harm reduction is all about.
1) Planning: why 4 days is often a logical basis
A commonly heard practical guideline is to set aside at least 3 to 4 days around a guided session. That is not a hard and fast rule, but it helps create space for preparation and recovery. Especially when traveling, extra time can make the difference between “cramming everything in” and “settling in sufficiently.”.
A commonly used diagram looks broadly like this:
Day 1: arrival and rest
Preferably plan a quiet arrival day. Travel, unexpected delays, sensory overload, and sleep deprivation can affect your resilience. Even without jet lag, it is often pleasant to get used to the surroundings in advance.
Day 2: preparatory alignment and session day
Depending on the setting, there is a preparatory alignment, followed by the session itself. The exact structure of a session varies by provider and context. In research, there is usually a fixed protocol. In a harm-reduction setting, the implementation can vary more, but good guidance remains focused on safety, the set and setting, and clear agreements.
Day 3: recovery and integration
Many people benefit from a day without obligations. Not because you are “sick,” but because your body and mind may need time to recover. Integration is often about quietly looking back: what did you experience, what touched you, and what do you want to take with you into your daily life?
Day 4: extra buffer and departure
An extra day is primarily practical: resting, walking, writing things down, another conversation, and only then traveling. For some, 3 days is sufficient, but 4 days simply provides more leeway.
2) Legality: why “MDMA therapy” is not the same as a regular treatment
In the Netherlands, various legal and practical frameworks exist regarding psychedelics, and it is important not to lump them together. Online discussions frequently conflate psilocybin (truffles), magic mushrooms, MDMA, and “therapy,” whereas the situation differs depending on the substance and context.
MDMA MDMA is a prohibited substance in the Netherlands. This means that MDMA-assisted therapy cannot currently be freely offered as a standard treatment. What is possible, however, is for MDMA sessions to take place within scientific research. Additionally, in practice, MDMA sessions are sometimes discussed in a harm-reduction context, where the focus is on risk reduction, preparation, and support, without framing it as medical treatment.
Psilocybin truffles are treated differently from magic mushrooms in the Netherlands. Truffles are available in smart shops, whereas magic mushrooms were banned in 2008. This explains why you encounter commercial “truffle sessions” in the Netherlands. Note, however, that such programs are usually positioned as coaching or wellness guidance, and not as medical treatment. That is a relevant difference in language and expectations.
It is wise to critically examine how each provider describes their services, what limits they set, and how transparent they are regarding safety, screening, and aftercare. If someone promises guarantees or acts as if there are no risks, that is a signal to be extra vigilant.
3) Intake: why screening is not a “formality”
A good intake is not intended to create barriers, but to reduce risks and assess whether guidance is appropriate. In online stories, it sometimes sounds as if “if you pay, you’re in.” In practice, however, a serious intake is actually a mark of quality, with room for asking follow-up questions and, if necessary, a clear “no” or “not yet.”.
Although we cannot provide individual medical advice here, it is generally known that an intake often looks at topics such as:
Medication and substance use
Some combinations can increase risks or significantly affect the experience. Therefore, a thorough intake will always ask about medication and usage patterns.
Physical health
Certain conditions can pose an increased risk when taking medications that strain the body. Therefore, an intake interview may ask about, for example, cardiovascular issues or other relevant medical history.
Psychological vulnerability and stability
A session can be intense. Counselors want to assess whether someone has sufficient support, stability, and opportunities for integration. Sometimes extra preparation is needed, or a different trajectory is more suitable.
Goals and expectations
“I want to get rid of my trauma” sounds understandable, but it is also a high bar. It helps if an intake session explores together what realistic goals are, what support you already have, and how you deal with difficult emotions.
In practice, an intake often takes place via an online questionnaire followed by a (video) call. Sometimes there is an additional preparatory call in the weeks before the session to discuss intention, set and setting, boundaries, and integration. In research settings, the procedure is generally stricter and more standardized.
4) What does research say (and what does it not say)?
It is tempting to look for a single number that proves everything, but psychedelic and MDMA research requires nuance. There are promising results, and at the same time, translating this to “this works for everyone” is too simplistic.
In discussions, two lines are often mentioned:
MDMA-assisted therapy for PTSD
Clinical studies have been published in which MDMA-assisted therapy has been investigated for post-traumatic stress. A known result from a phase 3 study (published in Nature Medicine, 2021) is that a large proportion of the participants no longer met the criteria for PTSD after completion. That is encouraging, but it remains research within strict frameworks, with carefully selected participants, extensive screening, and therapeutic guidance. It is no guarantee of individual outcomes.
Psilocybin for depression and anxiety
Universities such as Johns Hopkins have published studies on psilocybin-assisted therapy for depressive symptoms and anxiety, showing significant improvements in groups of participants. Here too, the following applies: research takes place in a controlled setting and with specific inclusion criteria. Commercial truffle sessions are not exactly the same as a research protocol.
A useful rule of thumb is: assessment can provide direction, but does not automatically indicate what is appropriate or safe for you. That is why intake, preparation, guidance, and integration remain so important.
5) Harm reduction in practice: what “good guidance” often entails
When MDMA sessions are discussed outside of research, this typically takes place in the Netherlands within a harm-reduction context. Harm reduction is not about encouraging use, but about minimizing harm and increasing safety if someone is considering a session.
Elements that often fit with harm reduction:
Clear boundaries and informed consent
What is the goal of the guidance, and what is it not? What role does the guide have, and what role do you have? What happens in case of tension, panic, or conflict? Making clear agreements beforehand prevents many problems.
Set and setting
“Set” refers to your mental and emotional state, “setting” to the environment. Peace, privacy, safety, and a plan for unexpected situations are basic, but are sometimes underestimated online.
Integration and aftercare
A strong experience is not the same as lasting change. Integration can consist of follow-up conversations, reflection, bodywork, adjusting daily routines, and seeking professional help in a timely manner if old symptoms worsen.
No promises, but realism
Some people experience relief, insight, or a new relationship with difficult memories. Others, however, experience confusion, rawness, or disappointment. Both are possible. Realistic preparation ensures that you are less “surprised” by the outcome.
6) Practical tip: book not only your session, but also the space surrounding it
Those coming from outside the Netherlands sometimes plan primarily logistics: flight, hotel, schedule. But in this type of process, “space” is often at least as important: sleep, healthy meals, silence, and someone to call when you feel vulnerable. It can also help not to fill your schedule immediately upon returning, so that integration can take place.
Moreover, if you are exploring MDMA in the Netherlands, it is wise to be extra critical of how a provider handles intake, safety, and boundaries. Precisely because MDMA is not freely available as regular therapy, you want maximum transparency regarding what is and is not offered.
Conclusion
MDMA therapy in the Netherlands requires a pragmatic view of planning, intake, and the legal context. A schedule of approximately four days is practical for many people, as it provides time for preparation, the session, and integration. At the same time, it is important to distinguish between legality and claims: MDMA sessions can currently only be discussed within the framework of scientific research or in practice via harm reduction. Research results are promising but do not guarantee an individual outcome, and commercial programs are not the same as clinical studies.
Anyone wishing to carefully explore their options and determine if an intake is appropriate can find more information and register via sign up for an MDMA session.
Source context: this article is inspired by questions arising in online discussions about guided sessions in the Netherlands, including this Q&A about truffle treatment. Personal stories can be valuable, but they are not a substitute for screening, professional support, and a realistic risk assessment.
English 
Dutch 
German 
French